Reversal of Hyperglycemia and Suppression of Type 1 Diabetes in the NOD Mouse with Apoptotic DNA Immunotherapy™ (ADi™), ADi-100

Biomedicines
David G AllevaAvnesh S Thakor

Abstract

The antigen-specific apoptotic DNA immunotherapeutic, ADi-100, is designed to suppress type 1 diabetes and consists of two DNA plasmids encoding genetic sequences of the apoptosis-inducing molecule, BAX, and the secreted form of the autoantigen, glutamic acid decarboxylase 65, that is CpG hyper-methylated to avoid inflammatory signaling (msGAD55). Upon a four-day treatment with ADi-100 of young female non-obese diabetic (NOD) mice, the frequency of various tolerogenic dendritic cell populations increased in draining lymph nodes; these cells lost the capacity to stimulate glutamic acid decarboxylase (GAD)-specific CD4+ T lymphocytes and were associated with the previously demonstrated enhancement of GAD-specific regulatory T cells. The efficacy of two ADi-100 formulations containing different proportions of BAX and msGAD55, 1:4 (10/40 µg) and 1:2 (17/33 µg), was evaluated in mildly hyperglycemic pre-diabetic NOD female mice. Both formulations suppressed the incidence of diabetes by 80% in an antigen-specific manner, while all untreated mice developed diabetes. However, treatment of pre-diabetic mice with significantly higher hyperglycemia, denoting progressive disease, showed that ADi-100 1:2 strongly suppressed diabetes inciden...Continue Reading

References

Jul 5, 2005·Journal of Diabetes and Its Complications·Carl-David AgardhAke Lernmark
Dec 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nanette SolvasonHideki Garren
Apr 9, 2010·Expert Opinion on Biological Therapy·Alice F Li, Alan Escher
Jan 21, 2011·Physiological Reviews·Tom L van BelleMatthias G von Herrath
Feb 3, 2012·The New England Journal of Medicine·Johnny LudvigssonSabine Baron
Feb 23, 2012·Cold Spring Harbor Perspectives in Medicine·Xavier Clemente-CasaresPere Santamaria
Nov 15, 2012·Immunotherapy·Nick Giannoukakis, Massimo Trucco
Dec 19, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stephan KontosJeffrey A Hubbell
Apr 12, 2013·Clinical and Experimental Immunology·M von HerrathB Roep
Jun 7, 2013·Science Translational Medicine·Andreas LutterottiRoland Martin
Aug 24, 2013·Frontiers in Immunology·Chantal KeijzerFemke Broere
Oct 30, 2013·Human Vaccines & Immunotherapeutics·Anna K E RydénMatthias G Von Herrath
Nov 19, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel R GettsStephen D Miller
Mar 5, 2014·Frontiers in Immunology·Ann-Katrin HoppVeronika Lukacs-Kornek
Aug 12, 2014·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Moufida Ben NasrPaolo Fiorina
Dec 3, 2014·Journal of Pharmaceutical Sciences·Brittany L HartwellCory Berkland
Feb 24, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Pau Serra, Pere Santamaria
Aug 19, 2015·Scientific Reports·Young Mee YoonBenjamin G Keselowsky
Oct 30, 2015·Scientific Reports·Alizée J GrimmJeffrey A Hubbell
Mar 8, 2016·Journal of Autoimmunity·Jane H Buckner, Gerald T Nepom
Apr 17, 2016·Journal of Autoimmunity·Balasubramanian KrishnamurthyThomas W H Kay
Sep 21, 2016·Seminars in Immunopathology·Maisa C Takenaka, Francisco J Quintana
Mar 9, 2017·Proceedings of the National Academy of Sciences of the United States of America·Novalia PisheshaHidde L Ploegh
Mar 28, 2017·Molecular Therapy. Methods & Clinical Development·Howard R SeayTodd M Brusko
Aug 5, 2017·Diabetologia·Caroline M HullTimothy I M Tree
Jun 11, 2019·The New England Journal of Medicine·Kevan C HeroldUNKNOWN Type 1 Diabetes TrialNet Study Group

❮ Previous
Next ❯

Citations

Nov 11, 2020·Current Diabetes Reports·Jeniffer D Loaiza NaranjoEmma E Hamilton-Williams

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry

Software Mentioned

GraphPad
Prism
Stata
FlowJo

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.